Log in
Enquire now

List of LifeArc patents

List of LifeArc patents
List of TerraNet AB (company) patents
List of Claria Corporation patents
List of Enerdel patents
List of companies in GL Capital's investment portfolio
List of companies in Chain Ridge Capital's investment portfolio
Patents where
Current Assignee
Name
is
LifeArcLifeArc
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11446351 Composition for treating one or more estrogen related diseases

LifeArc
LifeArc
LifeArc
LifeArc
United States Patent and Trademark Office
United States Patent and Trademark Office
11446351
September 20, 2022
‌
US Patent 11136338 Fused thiazolopyrimidine derivatives as MNKs inhibitors

Patent 11136338 was granted and assigned to LifeArc on October, 2021 by the United States Patent and Trademark Office.

LifeArc
LifeArc
LifeArc
LifeArc
United States Patent and Trademark Office
United States Patent and Trademark Office
11136338
October 5, 2021
‌
US Patent 10961319 Anti-transglutaminase 2 antibodies

Patent 10961319 was granted and assigned to LifeArc on March, 2021 by the United States Patent and Trademark Office.

LifeArc
LifeArc
LifeArc
LifeArc
United States Patent and Trademark Office
United States Patent and Trademark Office
10961319
March 30, 2021
‌
US Patent 10961233 Oxazole derivatives for use in the treatment of cancer

Patent 10961233 was granted and assigned to LifeArc on March, 2021 by the United States Patent and Trademark Office.

LifeArc
LifeArc
LifeArc
LifeArc
United States Patent and Trademark Office
United States Patent and Trademark Office
10961233
March 30, 2021
‌
US Patent 10669284 Fused thiazolopyrimidine derivatives as MNKS inhibitors

LifeArc
LifeArc
LifeArc
LifeArc
United States Patent and Trademark Office
United States Patent and Trademark Office
10669284
June 2, 2020
‌
US Patent 10961234 Oxazole derivatives for use in the treatment of cancer

Patent 10961234 was granted and assigned to LifeArc on March, 2021 by the United States Patent and Trademark Office.

LifeArc
LifeArc
LifeArc
LifeArc
United States Patent and Trademark Office
United States Patent and Trademark Office
10961234
March 30, 2021
‌
US Patent 10005846 Anti-transglutaminase 2 antibodies

Patent 10005846 was granted and assigned to LifeArc on June, 2018 by the United States Patent and Trademark Office.

‌
Medical Research Council Technology
LifeArc
LifeArc
United States Patent and Trademark Office
United States Patent and Trademark Office
10005846
June 26, 2018
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us